Franchise News


Franchise News

FDA Warns of Cognitive Effects of New Cholesterol Drugs

The U.S. Food and Drug Administration has been looking into harmful effects that new cholesterol drugs have on cognitive function. Sanofi SA, one of the large drug firms developing the drugs, said in its annual report on Friday that the FDA asked them to evaluate the neurocognitive negative impacts of its drugs, one of which is called PCSK9 inhibitors.


Latest News










Real Time Analytics